Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
TOPACIO/Keynote-162: Niraparib plus pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial
ÌÇÐÄ´«Ã½
TOPACIO/Keynote-162: Niraparib plus pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial Vinayak, S., Tolaney, S. M., Schwartzberg, L., Mita, M. M., McCann, G., Tan, A. R., Hendrickson, A., Forero-Torres, A., Anders, C. K., Wulf, G. M., Dillon, P. M., Lynce, F., Zarwan, C., Erban, J., Dezube, B., Zhou, Y., Buerstatte, N., Arora, S., Achour, H., Telli, M. L. AMER SOC CLINICAL ONCOLOGY. 2018View details for
View details for